LumiraDX Ltd.(NASDAQ : LMDX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||-0.54%||592.85||1.0%||$746.92m|
|ISRG||Intuitive Surgical, Inc.||-0.34%||228.92||0.8%||$501.52m|
|BSX||Boston Scientific Corp.||0.15%||42.50||1.0%||$304.90m|
|ALGN||Align Technology, Inc.||1.35%||281.40||6.4%||$260.65m|
|EW||Edwards Lifesciences Corp.||-1.59%||98.94||0.4%||$249.90m|
|BDX||Becton, Dickinson & Co.||-0.61%||262.61||1.0%||$231.14m|
|IDXX||IDEXX Laboratories, Inc.||-0.08%||373.70||3.9%||$219.14m|
|A||Agilent Technologies, Inc.||-1.95%||139.51||1.7%||$200.48m|
|BAX||Baxter International, Inc.||-1.52%||60.45||1.8%||$198.89m|
LumiraDX Ltd. is a next-generation point of care diagnostics company, which engages in the provision of an innovative diagnostic platform that supports a menu of tests with lab-comparable performance at the point of care. The firm's diagnostic testing solutions are being deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness as well as disease. It also has a comprehensive portfolio of COVID-19 testing solutions from the lab to point of need. The company was founded by Ronald Zwanziger, David Scott, and Jerry McAleer in 2014 and is headquartered in London, the United Kingdom.